Last year, while Georgia Attorney General Chris Carr was negotiating a settlement agreement with Johnson & Johnson and the nation’s three major pharmaceutical manufacturers, he also received thousands in campaign contributions from a trade association that lobbies on behalf of the pharmaceutical industry.

Johnson & Johnson, plus Cardinal, McKesson and AmerisourceBergen, agreed to a multistate, $26 billion settlement regarding claims of their roles in the nation’s opioid epidemic. Georgia will get $626 million in the agreement, which Carr signed off on in January.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]